[#item_full_content]
Year: 2023
Light & Wonder Completes Acquisition of Remaining Public Shares of SciPlay
[#item_full_content]
Compelling Data in Breast Cancer Treatment with First-In-Class Cyclin A/B Inhibitor Presented at 2023 AACR-NCI-EORTC International Conference
[#item_full_content]SAN FRANCISCO–(BUSINESS WIRE)– #BreastCancer–Circle Pharma, in collaboration with the laboratory of Violeta Serra, Ph.D., at Vall…
Top economists unanimous on ‘higher for longer’ rates as inflation threats linger
[#item_full_content]Top economists and central bankers appear to be in agreement on one thing — and it’s…
[#item_full_content]